Also, age of first tumor onset and Ki67 proliferation indices in patients with the P/LP PALB2 variant were similar to BRCA2-associated tumor patients (Figure 1b), and no difference in multiplex tumor occurrence among BRCA1, BRCA2, or PALB2 carriers were observed. This evidence concerns the gene BRCA2 and neoplasm.